SYNGR3

Across TCGA pan-cancer cohorts, SYNGR3 mass-spec protein differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of SYNGR3’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where SYNGR3 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types SYNGR3 is over-expressed in tumor, although a few such as CCRCC and COAD show the opposite, repressed pattern.

CCRCC, LSCC, and COAD are the cancer types where SYNGR3 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SYNGR3 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	All	All	−0.813	<.001	7	view →
LSCC	All	All	+1.101	<.001	6	view →
COAD	All	All	−1.610	.011	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

SYNGR3–CCRCC

Open the CCRCC breakdown →